Join
Live feed
·
INSIDERFilingvia Quantisnow
Olema Pharmaceuticals Inc. logo

CH. DISCOV. & NON-CLIN DEV OFF Myles David C. was granted 48,750 shares and sold $234,916 worth of shares (26,066 units at $9.01), increasing direct ownership by 4% to 598,333 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
OLMA· Olema Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OLMA (Olema Pharmaceuticals Inc.) and more on Quantisnow.

CH. DISCOV. & NON-CLIN DEV OFF Myles David C. was granted 48,750 shares and sold $234,916 worth of shares (26,066 units at $9.01), increasing direct ownership by 4% to 598,333 units (SEC Form 4) | Quantisnow